Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. Luzzago is active.

Publication


Featured researches published by S. Luzzago.


Ejso | 2018

In-hospital length of stay after major surgical oncological procedures

Sebastiano Nazzani; Felix Preisser; Elio Mazzone; Zhe Tian; Francesco Mistretta; Shahrokh F. Shariat; Fred Saad; Markus Graefen; Derya Tilki; E. Montanari; S. Luzzago; Alberto Briganti; Luca Carmignani; Pierre I. Karakiewicz

BACKGROUND AND OBJECTIVESnEnhanced recovery after surgery protocols (ERAS) have been developed and implemented as of 2001. However, no previous analyses targeted length of stay (LOS) changes over time after major surgical oncological procedures (MSOPs).nnnMETHODSnBetween 2003 and 2013, we retrospectively identified patients, who underwent prostatectomy, colectomy, cystectomy, mastectomy, gastrectomy, hysterectomy, nephrectomy, oophorectomy, lung resection or pancreatectomy within the Nationwide Inpatient Sample. A total of 3 431 602 assessable patients were identified. We examined temporal trends of LOS after ten MSOPs, as well as LOS determinants and the impact of LOS on total hospital charges (THCGs). Univariable and multivariable linear, log-linear, logistic (MLR) and Poisson regression (MPR) analyses were used.nnnRESULTSnMean and median LOS were respectively 6 and 4 days (IQR 2-7). During the study span, LOS decreased [Estimated annual percentage change (EAPC):xa0-1.89%, pxa0=xa00.0002]. Of the ten examined MSOPs, nine showed a decrease that ranged fromxa0-4.47% in prostatectomy toxa0-0.7% in mastectomy. Conversely, no decrease in LOS was recorded for colectomy (EAPC:+0.37, pxa0=xa00.015). In MPR analyses, robotic [Relative risk (RR):0.68, pxa0=xa00.0003] and laparoscopic (RR: 0.90, pxa0<xa00.0001) surgical approaches were associated with shorter LOS. LOS was directly related to THCGs.nnnCONCLUSIONSnSince the implementation of ERAS protocols, LOS has decreased for nine out of ten MSOPs in a significant fashion. Although these gains may appear marginal on an annual basis, their cumulative effect, over the study span, ranges for 7.7%-49.2%, which can hardly be interpreted as marginal. LOS decrease directly translates in THCGs savings.


European Urology Supplements | 2018

Low risk prostate cancer in the contemporary magnetic-resonance ERA: Are we excluding too much patients suitable for active surveillance?

M. Catellani; S. Luzzago; F.A. Mistretta; A. Conti; E. Di Trapani; G. Cozzi; R. Bianchi; Sarah Alessi; Antonio Cioffi; Paola Pricolo; Matteo Ferro; D.V. Matei; G. Petralia; Gennaro Musi; O. De Cobelli


European Urology Supplements | 2018

Multiparametric magnetic resonance (mpMRI) of the prostate during active surveillance for low-risk prostate cancer: Time to reduce the number of follow-up biopsies?

S. Luzzago; M. Catellani; F.A. Mistretta; A. Conti; E. Di Trapani; G. Cozzi; R. Bianchi; Giovanni Cordima; Sarah Alessi; Matteo Ferro; M. Delor; D.V. Matei; G. Petralia; Gennaro Musi; O. De Cobelli


European Urology Supplements | 2018

Oncological outcomes and management changes over A 13 years experience on active surveillance for low-risk prostate cancer. Results of a single high-volume center

M. Catellani; S. Luzzago; F.A. Mistretta; A. Conti; E. Di Trapani; R. Bianchi; G. Cozzi; Matteo Ferro; Gennaro Musi; D.V. Matei; O. De Cobelli


European Urology Supplements | 2018

In-bore magnetic resonance (mpMRI)-guided biopsies represent the future of prostate cancer diagnosis? A single center experience and implications for focal therapy

S. Luzzago; M. Catellani; F.A. Mistretta; A. Conti; Paola Pricolo; A. Serino; R. Bianco; Sarah Alessi; A. Brescia; E. Di Trapani; Matteo Ferro; D.V. Matei; G. Petralia; Gennaro Musi; O. De Cobelli


European Urology Supplements | 2018

Oligometastatic prostate cancer: The importance of a multidisciplinary approach in a high volume robotic center

F.A. Mistretta; A. Conti; M. Catellani; M. Delor; A. Serino; S. Luzzago; G. Cozzi; Matteo Ferro; D.V. Matei; Gennaro Musi; E. Verri; Barbara Alicja Jereczek-Fossa; O. De Cobelli


European Urology Supplements | 2018

Feasibility of a novel port placement technique for robotic retroperitoneal salvage lymph node dissection for testicular cancer

A. Conti; F.A. Mistretta; S. Luzzago; M. Catellani; E. Di Trapani; G. Cozzi; R. Bianchi; Matteo Ferro; D.V. Matei; Gennaro Musi; O. De Cobelli


European Urology Supplements | 2018

Active surveillance in a high-volume centre: Oncological outcomes and management changes during a 12 years experience

M. Catellani; S. Luzzago; F.A. Mistretta; A. Conti; Andrea Russo; R. Bianchi; E. Di Trapani; G. Cozzi; G. Petralia; Matteo Ferro; Gennaro Musi; D.V. Matei; O. De Cobelli


European Urology Supplements | 2018

Multiparametric magnetic resonance of the prostate second opinion may reduce the number of unnecessary biopsies: A single center experience

S. Luzzago; M. Catellani; F.A. Mistretta; A. Conti; A. Serino; R. Bianco; Andrea Russo; E. Di Trapani; Matteo Ferro; Sarah Alessi; G. Petralia; Gennaro Musi; D.V. Matei; O. De Cobelli


European Urology Supplements | 2018

Positive surgical margins after robot-assisted radical prostatectomy in the multiparametric MRI era: The experience of a high volume third referral centre

F.A. Mistretta; D.V. Matei; R. Bianchi; E. Di Trapani; A. Conti; Sarah Alessi; V. Tringali; S. Luzzago; Andrea Russo; Matteo Ferro; Gennaro Musi; G. Petralia; Giuseppe Renne; O. De Cobelli

Collaboration


Dive into the S. Luzzago's collaboration.

Top Co-Authors

Avatar

Gennaro Musi

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

O. De Cobelli

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

D.V. Matei

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

F.A. Mistretta

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matteo Ferro

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

R. Bianchi

Guy's and St Thomas' NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

G. Cozzi

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrea Russo

Vita-Salute San Raffaele University

View shared research outputs
Researchain Logo
Decentralizing Knowledge